Total Payments
$6,080
2024 Payments
$42.54
Companies
27
Transactions
428
Medicare Patients
1,152
Medicare Billing
$91,244
Payment Breakdown by Category
Food & Beverage$5,989 (98.5%)
Education$90.93 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,989 | 424 | 98.5% |
| Education | $90.93 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $817.37 | 57 | $0 (2023) |
| Novo Nordisk Inc | $691.94 | 51 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $621.93 | 33 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $487.49 | 33 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $435.03 | 30 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $410.84 | 33 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $356.61 | 24 | $0 (2019) |
| Astellas Pharma US Inc | $342.53 | 17 | $0 (2020) |
| Lilly USA, LLC | $322.85 | 28 | $0 (2019) |
| Amgen Inc. | $308.13 | 19 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.54 | 2 | Vifor Pharma, Inc. ($24.51) |
| 2023 | $108.00 | 6 | Novo Nordisk Inc ($52.72) |
| 2022 | $56.86 | 3 | Novo Nordisk Inc ($34.81) |
| 2021 | $40.53 | 3 | Novo Nordisk Inc ($28.97) |
| 2020 | $61.74 | 4 | Novo Nordisk Inc ($29.96) |
| 2019 | $2,190 | 134 | GlaxoSmithKline, LLC. ($354.26) |
| 2018 | $1,626 | 116 | GlaxoSmithKline, LLC. ($244.18) |
| 2017 | $1,954 | 160 | Allergan Inc. ($239.53) |
All Payment Transactions
428 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Hyperkalemia | ||||||
| 11/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 10/12/2023 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Hyperkalemia | ||||||
| 07/25/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Diabetes | ||||||
| 05/10/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Oncology | ||||||
| 02/28/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Diabetes | ||||||
| 12/06/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 10/25/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 06/27/2022 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Hyperkalemia | ||||||
| 12/08/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 05/25/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 02/23/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 07/28/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 06/30/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Diabetes | ||||||
| 02/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: Cardiovascular | ||||||
| 01/07/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: UROLOGY | ||||||
| 12/09/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: DIABETES | ||||||
| 12/02/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.43 | General |
| 11/19/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: UROLOGY | ||||||
| 11/14/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/14/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 339 | 448 | $73,770 | $28,921 |
| 2022 | 11 | 348 | 515 | $78,876 | $27,842 |
| 2021 | 8 | 256 | 287 | $53,785 | $19,642 |
| 2020 | 7 | 209 | 271 | $43,674 | $14,839 |
Total Patients
1,152
Total Services
1,521
Medicare Billing
$91,244
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 150 | $36,450 | $12,073 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $18,104 | $8,717 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 63 | $10,836 | $3,527 | 32.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 33 | 36 | $4,788 | $2,712 | 56.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 41 | $1,845 | $1,173 | 63.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 42 | $1,134 | $430.82 | 38.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 24 | $480.00 | $228.48 | 47.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 15 | 19 | $133.00 | $60.99 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 174 | $42,261 | $12,569 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 74 | 74 | $18,415 | $9,029 | 49.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 43 | $7,386 | $1,726 | 23.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 22 | 22 | $2,926 | $1,546 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $4,125 | $1,138 | 27.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,170 | $703.19 | 60.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 49 | $1,323 | $463.94 | 35.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $675.00 | $407.69 | 60.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 19 | 22 | $440.00 | $211.03 | 48.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 13 | 13 | $91.00 | $41.95 | 46.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 12 | 64 | $64.00 | $5.47 | 8.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 74 | 95 | $22,955 | $7,118 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 35 | 35 | $8,651 | $4,376 | 50.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 56 | $9,601 | $3,390 | 35.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $7,950 | $2,511 | 31.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 26 | 26 | $3,172 | $1,697 | 53.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $1,125 | $390.50 | 34.7% |
About Dr. Crystal Martin, M.D
Dr. Crystal Martin, M.D is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1801059332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Crystal Martin, M.D has received a total of $6,080 in payments from pharmaceutical and medical device companies, with $42.54 received in 2024. These payments were reported across 428 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,989).
As a Medicare-enrolled provider, Martin has provided services to 1,152 Medicare beneficiaries, totaling 1,521 services with total Medicare billing of $91,244. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Lexington, KY
- Active Since 07/03/2008
- Last Updated 10/17/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801059332
Products in Payments
- Ozempic (Drug) $460.18
- JANUVIA (Drug) $390.80
- TRELEGY ELLIPTA (Drug) $378.24
- XARELTO (Drug) $345.99
- JARDIANCE (Drug) $259.16
- TOUJEO (Drug) $237.97
- MYRBETRIQ (Drug) $237.85
- Prolia (Biological) $212.96
- ANORO (Drug) $211.26
- FARXIGA (Drug) $187.06
- TRULICITY (Drug) $178.21
- BEVESPI AEROSPHERE (Drug) $171.86
- LONHALA MAGNAIR (Drug) $147.43
- CHANTIX (Drug) $143.58
- SYMBICORT (Drug) $139.97
- XIFAXAN (Drug) $112.62
- ENTRESTO (Drug) $105.15
- Veltassa (Drug) $100.89
- Victoza (Drug) $96.65
- BREO (Drug) $95.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
Family Medicine $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Family Medicine $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
Family Medicine $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Family Medicine $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Family Medicine $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475
Family Medicine $11,475